Integrated systems of stroke care and reduction in 30-day mortality
A retrospective analysis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 15, 2015
- Accepted in final form October 7, 2015
- First Published February 5, 2016.
Article Versions
- Previous version (February 5, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Aravind Ganesh, MD,
- Patrice Lindsay, RN, PhD,
- Jiming Fang, PhD,
- Moira K. Kapral, MD, MSc, FRCPC,
- Robert Côté, MD,
- Ian Joiner,
- Antoine M. Hakim, MD, PhD and
- Michael D. Hill, MD, MSc, FRCPC
- Aravind Ganesh, MD,
NONE
NONE
(1) The Meritas Seminar Series, Oxford: speaker honorarium (2) University of Calgary Post-Graduate Medical Education (PGME): travel funding for conferences
(1) Neurology Resident & Fellow Section, Editorial Board Member, 2014-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) The Rhodes Trust
(1) SnapDx (2) TheRounds.ca (3) The Self-Care People
NONE
NONE
NONE
NONE
NONE
- Patrice Lindsay, RN, PhD,
NONE
NONE
Hotel costs and honorarium of $500 from Young Stroke Inc., a stroke survivor organization in the USA, for speaking at conference in June 2015. Topic unrelated to this manuscript.
International Journal of Stroke: Section Editor, Clinical Guidelines (2014-present). No financial compensation received.
NONE
NONE
NONE
NONE
NONE
Employee of the Heart and Stroke Foundation of Canada; Member, Board of Directors for World Stroke Organization
NONE
NONE
NONE
NONE
I am an employee of the Heart and Stroke Foundation of Canada. Data analysis for this study was funded by the HSFC alone and no industry funds were used.
NONE
NONE
NONE
NONE
NONE
NONE
- Jiming Fang, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Moira K. Kapral, MD, MSc, FRCPC,
NONE
NONE
NONE
Stroke journal - editorial board Circulation Cardiovascular Quality and Outcomes - guest editor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Heart and Stroke Foundation of Canada, Ontario Provincial Office - Career Investigator Award, 2011 to present
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Côté, MD,
1))DSMB for National Institute of Health (POINT study) 2)Outcomes committee for the IRIS trial (NIH funded)
NONE
1)Bristol Myers Squibb,speaker honoraria 2)Pfizer,speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ian Joiner,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I was an employee of the Heart and Stroke Foundation of Canada when this was submitted.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Antoine M. Hakim, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael D. Hill, MD, MSc, FRCPC
Vernalis Group Ltd Advisory board - 2008 Genentech Ltd Advisory board - 2007 Sanofi Canada Ltd Advisory board - 2009 Hoffmann-La Roche Canada Ltd advisory board - 2010 Bayer Canada Advisory Board - 2011 Boehringer-Ingelheim Canada Advisory Board - 2011 BMS-Pfizer Alliance Advisory Board - 2015 ARUBA study DSMB - ended 2013 SHINE study DSMB - ongoing Aldagen study DSMB - ended 2014 BRAIN-AF study DSMB - ongoing ARTESIA study DSMB - ongoing
NONE
NONE
Editorial board - Stroke (ongoing), Can J Neurological, Sciences (ongoing), International Journal of Stroke (ongoing), Neurology (ended 2010) Editor - Stroke Rounds (Canada) (ended 2010)
Patent pending. 62/086,077 Systems and Methods for Assisting in Decision-Making and Triaging for Acute Stroke Patients
NONE
NONE
Heart & Stroke Foundation Alberta/NWT/NU Board of Directors - 2009-2011 [Charitable sector] Heart & Stroke Foundation Alberta/NWT/NU Advisory Board of Directors (Past-Chair) - 2011-2015 [Charitable sector] Canadian Neuroscience Federation - 2012-2016 Board of Directors [Not-for-profit sector] QuikFLO Health Inc. - 2015-present - Board of Directors [For profit sector]
NONE
NONE
NONE
Grant funding from industry - Hoffmann-La Roche Canada 2004 & 2009, Bayer Canada 2007, Merck Canada 2003-2007, Covidien(Medtronic) 2013-2015
NIH (NINDS) (2001-ongoing) CIHR (1999-ongoing) Alberta Heritage Foundation for Medical Research (2007-2014) Alberta Innovates Health Solutions 2014-2019
Canadian Stroke Network (2008-2013) [Public funding sector]
Heart & Stroke Foundation Alberta (1999-ongoing) [Charitable funding sector]
QuikFLO Health Incorporated (hold stock, hold stock options)
NONE
NONE
NONE
Calgary Scientific Incorporated (hold stock).
NONE
Executive committee of IMS-3 trial CoPI/executive committee of the ALIAS trial PI of ENACT trial PI of ESCAPE trial
- From the Calgary Stroke Program, Department of Clinical Neurosciences (A.G.), and Departments of Clinical Neurosciences, Medicine, Radiology, and Community Health Sciences, Hotchkiss Brain Institute, Faculty of Medicine (M.D.H.), University of Calgary; The Heart & Stroke Foundation of Canada (P.L., I.J.), Ottawa; Institute for Clinical Evaluative Sciences (J.F., M.K.K.), Toronto; Department of Medicine (M.K.K.), University of Toronto; Department of Neurology (R.C.), McGill University, Montréal; and Division of Neurology and Ottawa Hospital Research Institute (A.M.H.), University of Ottawa and The Heart & Stroke Foundation Centre for Stroke Recovery, Ottawa, Canada.
- Correspondence to Dr. Hill: michael.hill{at}ucalgary.ca
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.